Aspiriant Holdings S3’s Pfizer PFE Stock Holding History

Aspiriant Holdings S3’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,559	Closed	-$216K	–	108
2015 Q1	$216K	Buy	+6,559	New	+$209K	0.09%	107
2014 Q4	–	Sell	-9,790	Closed	-$275K	–	115
2014 Q3	$275K	Sell	9,790 -101,814	-91%	-$2.86M	0.11%	98
2014 Q2	$3.14M	Sell	111,604 -3,025	-3%	-$86.2K	1.25%	34
2014 Q1	$3.49M	Sell	114,629 -6,261	-5%	-$187K	1.47%	31
2013 Q4	$3.51M	Buy	120,890 +359	+0.3%	+$10.4K	1.38%	38
2013 Q3	$3.29M	Buy	120,531 +2,911	+2%	+$79.2K	1.39%	40
2013 Q2	$3.13M	Buy	+117,620	New	+$3.25M	1.41%	37

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aspiriant Holdings S3's PFE Position: Q2 2015 in Review

Aspiriant Holdings S3 sold out of Pfizer (PFE) in Q2 2015, closing a stake of 6,559 shares — an estimated $216K sold.

Aspiriant Holdings S3 first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $3.51M in Q4 2013. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

Aspiriant Holdings S3 reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
Aspiriant Holdings S3 sold 6,559 Pfizer shares in Q2 2015, an estimated $216K.
Aspiriant Holdings S3 first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
Aspiriant Holdings S3's Pfizer position peaked at $3.51M in Q4 2013.
1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Aspiriant Holdings S3's 13F filing for Q2 2015, filed 30 Jul 2015.